| John Devane PhD, Executive Director & Chief Executive Officer Dr
Devane has been the chief executive officer of
AGI since its formation in 2003 and was chief executive
officer of Athpharma Limited from 2001 to 2005.
Prior to this, Dr Devane worked in a number of
roles in research and development, clinical and
regulatory affairs and product development for Élan
Corporation plc (1981-2001) and its subsidiary
companies including executive vice president, R&D, Élan
Drug Delivery (1996-2001); vice president, R&D, Élan
Corporation plc (1993-1996); vice president, regulatory & clinical
affairs, Élan Pharma USA (1990-1993) and
director, product development, Élan Corporation
plc (1987-1990).
Dr Devane studied pharmacology
at University College Dublin and received his BSc
(Hons) in 1978 and was conferred with a PhD in
1982 also from UCD. Dr Devane also holds a certified
diploma in accounting and finance (Association
of Certified Accountants), has published in the
scientific area, is the author of a number of book
chapters and has been an invited speaker at international
scientific/technical conferences.
|
|
